Longitudinal prostaglandin E2 generation in various organs during evolution of experimental portal hypertension

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 4, 2002, Pages 197-201

  Ackerman, Z ^a   Karmeli, F ^a   Rachmilewitz, D ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2;

ABDOMINAL SURGERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD PRESSURE MEASUREMENT; COLON; CONTROLLED STUDY; HEMODYNAMICS; LUNG; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; SPLEEN; VASODILATATION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BODY WEIGHT; DISEASE COURSE; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BODY WEIGHT; DINOPROSTONE; DISEASE PROGRESSION; HEMODYNAMIC PROCESSES; HYPERTENSION, PORTAL; LIVER; LUNG; MALE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TIME FACTORS;

EID: 0036797541     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0419     Document Type: Article

References (31)

1. Groszmann R. J. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences. Hepatology 1994; 20: 1359-1363.
2. Henriksen J. H., Møller S. Haemodynamics and fluid retention in liver disease. Ital J Gastroenterol Hepatol 1998; 30: 320-332.
3. Murray B. M., Paller M. S. Decreased pressor reactivity to angiotensin II in cirrhotic rats: Evidence for post-receptor defect in angiotensin action. Circ Res 1985; 57: 424-431.
4. Benoit J. N., Barrowman J. A., Harper S. L., Kvietys P. R., Granger N. D. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol 1984; 247: G486-G493.
5. Benoit J. N., Zimmerman B., Premen A. J., Go V. L. N., Granger D. N. Role of glucogen in splanchnic hyperemia of portal hypertension. Am J Physiol 1986; 251: G674-G677.
6. Thomas S. H., Joh T., Benoit J. N. Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension. Dig Dis Sci 1991; 36: 1243-1248.
7. Wu J., Burns R. C., Sitzmann J. V. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology 1993; 18: 1416-1421.
8. Bruix J., Bosch J., Kravetz D., Mastai R., Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of liver. Gastroenterology 1985; 88: 430-435.
9. Wernze H., Tittor W., Goering H. Release of prostanoids into the portal and hepatic vein in patients with chronic liver disease. Hepatology 1986; 6: 911-916.
10. Guarner C., Soriano G. Prostaglandin and portal hypertension. Prostaglandins, Leukot Essent Fatty Acids 1993; 48: 203-206.
11. Tietge U. J. F., Fauler J., Bahr M. J., Manns M. P., Boker K. H. W. Local prostaglandin levels and hepatic hemodynamics in cirrhosis. Gastroenterology 1996; 110: A1345 (Abstract).
12. 2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats. Gastroenterology 1997; 112: 208-213.
13. 1 alpha in the course of liver cirrhosis. Prostaglandins 1997; 53: 11-20.
14. Hamilton G., Phing R. C. F., Hutton R. A., Dandona P., Hobbs K. F. The relationship between prostacyclin activity and pressure in the portal vein. Hepatology 1982; 2: 236-242.
15. Sitzmann J. V., Li S. S., Adkinson F. Evidence for role of prostacyclin as systemic hormone in portal hypertension. Surgery 1991; 109: 149-153.
16. Oberti F., Songi P., Cailmail S., Moreau R., Pipy B., Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 1993; 18: 621-627.
17. Taylor L., Foxall T., Auger K., Heinsohn C., Polgar P. Comparison of prostaglandin synthesis by endothelial cells from blood vessels originating in the rat, baboon, calf and human. Atherosclerosis 1987; 65: 227-236.
18. Voelkel N. F., Gerber J. G., McMurtry I. F., Reeves J. T., Nies A. S. Release of dilator prostaglandins from rat lung during angiotensin II induced vasoconstriction. Adv Prostaglandin Thromboxane Res 1980; 7: 957-960.
19. 2 in the normal and spontaneously hypertensive rat. Prostaglandins 1978; 15: 999-1003.
20. 2on the rat mesentery in vitro and in vivo. Prostaglandins Leukot Med 1983; 10: 257-268.
21. Ackerman Z., Karmeli F., Amir G., Rachmilewitz D. Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension. Liver 1996; 16: 12-18.
22. Sikuler E., Kravetz D., Groszmann R. J. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985; 248: G618-G625.
23. Groszmann R. J., Colombato L. A. Gastric vascular changes in portal hypertension. Hepatology, 1988; 8: 1708-1710.
24. Ackerman Z., Karmeli F., Amir G., Rachmilewitz D. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. J Hepatol 1996; 24: 478-486.
25. Fallon M. B., Abrams G. A. Pulmonary dysfunction in chronic liver disease. Hepatology 2000; 32: 859-865.
26. Castro M., Krowka M. J. Hepatopulmonary syndrome: A pulmonary vascular complication in liver disease. Clin Chest Med 1996; 17: 35-48.
27. 2 alpha and indomethacin in hepatogenic pulmonary angiodysplasia. Effects on pulmonary hemodynamics and gas exchange. Chest 1991; 100: 873-875.
28. Schraufnagel D. E., Malik R., Goel V., Ohara N., Chang S. N. Lung capillary changes in hepatic cirrhosis in rats. Am J Physiol 1977; 272: L139-L147.
29. Riegler J. L., Lang K. A., Johnson S. P., Westerman J. H. Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterology 1995; 109: 978-983.
30. Yonei Y., Guth P. H. Laparotomy stimulates an endogenous gastric mucosal protective mechanism in the rat. A microcirculatory and morphologic study of ethanol injury. Gastroenterology 1988; 95: 600-611.
31. Scherer B., Schnermann J., Sofroniev M., Weber P. C. Prostaglandin analysis in urine of humans and rats by different radioimmunoassays. Effects on prostaglandin-excretion by prostaglandin synthetase inhibitors, laparotomy and furosemide. Prostaglandins 1978; 15: 255-266.